Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins

55Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Arterial plasma kinins and mean arterial pressure were measured in intact and bilaterally nephrectomized rats infused with vehicle or bradykinin to study the role of 1) angiotensin converting enzyme (ACE) and other peptidases and 2) the kidney (a kininase-rich organ) in the metabolism of kinins in vivo. Before the infusion, rats were pretreated with vehicle, enalaprilat (an ACE inhibitor), or a cocktail of kininase inhibitors containing 1) enalaprilat, 2) DL-2-mercaptomethyl-3-gunanidinoethyl-thiopropanoic acid (MGTA), a carboxypeptidase N inhibitor, 3) phosphoramidon, a neutral endopeptidase 24.11 inhibitor, and 4) bestatin, an aminopeptidase B inhibitor. In the rats with vehicle (n = 8), the cocktail did not significantly increase endogenous kinins (from 31 ± 6 to 41 ± 9 pg/ml, p = 0.94). In the rats infused with bradykinin (peptidase substrate), plasma kinins increased threefold in the group pretreated with the vehicle, 21-fold in the enalaprilat group, and 22-fold in the cocktail group. These increases were doubled by nephrectomy but were not affected by ureteral ligation. In the groups pretreated with the cocktail or enalaprilat, the hypotensive effect of bradykinin was correlated with plasma kinin concentration (r = 0.75, p < 0.001). After bradykinin infusion was stopped, plasma kinins decreased by half in 10-12 seconds in the rats pretreated with vehicle, enalaprilat, or cocktail. We concluded that ACE and the kidney are important to the metabolism of circulating kinins while carboxypeptidase N, neutral endopeptidase 24.11 and aminopeptidase B are not. We also concluded that other tissue peptidases, not affected by either the above inhibitors or nephrectomy, play an important role in kinin metabolism.

Cited by Powered by Scopus

The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins

297Citations
N/AReaders
Get full text

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: Rank efficacy of enzymes associated with bradykinin-mediated angioedema

118Citations
N/AReaders
Get full text

Vasopeptidase inhibitors

114Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ishida, H., Scicli, A. G., & Carretero, O. A. (1989). Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins. Hypertension, 14(3), 322–327. https://doi.org/10.1161/01.HYP.14.3.322

Readers over time

‘09‘13‘16‘17‘18‘20‘2200.511.52

Readers' Seniority

Tooltip

Professor / Associate Prof. 3

50%

Researcher 3

50%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 3

43%

Medicine and Dentistry 2

29%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Immunology and Microbiology 1

14%

Save time finding and organizing research with Mendeley

Sign up for free
0